首页> 外文期刊>Journal of Medical Case Reports >Persisting right-sided chylothorax in a patient with chronic lymphocytic leukemia: a case report
【24h】

Persisting right-sided chylothorax in a patient with chronic lymphocytic leukemia: a case report

机译:慢性淋巴细胞性白血病患者坚持右侧乳糜胸1例

获取原文
           

摘要

Introduction Chylothorax caused by chronic lymphocytic leukemia is very rare and the best therapeutic approach, especially the role of modern immunochemotherapy, is not yet defined. Case presentation We present the case of a 65-year-old male Caucasian patient with right-sided chylothorax caused by a concomitantly diagnosed chronic lymphocytic leukemia. As first-line treatment four cycles of an immunochemotherapy, consisting of fludarabine, cyclophosphamide and rituximab were administered. In addition, our patient received total parenteral nutrition for the first two weeks of treatment. Despite the very good clinical response of the lymphoma to treatment, the chylothorax persisted and percutaneous radiotherapy of the thoracic duct was applied. However, eight weeks after the radiotherapy the chylothorax still persisted and our patient agreed to a surgical intervention. A ligation of the thoracic duct via a muscle sparing thoracotomy was performed, resulting in a complete cessation of the pleural effusion. Apart from the first two weeks our patient was treated on an out-patient basis for nearly six months. Conclusion In this case of chylothorax caused by chronic lymphocytic leukemia, immunochemotherapy in combination with conservative treatment, and even consecutive radiotherapy, were not able to stop pleural effusion, despite the very good clinical response of the chronic lymphocytic leukemia to treatment. Out-patient management using repetitive thoracocenteses can be safe as bridging until definitive surgical ligation of the thoracic duct.
机译:引言慢性淋巴细胞性白血病引起的百日咳是非常罕见的,最佳治疗方法,特别是现代免疫化学疗法的作用,目前尚无定论。病例介绍我们介绍了一名65岁男性白种人患者,患有右侧乳糜胸并伴有慢性淋巴细胞白血病。作为一线治疗,进行了由氟达拉滨,环磷酰胺和利妥昔单抗组成的四个免疫化学疗法周期。此外,我们的患者在治疗的前两周接受了全胃肠外营养。尽管淋巴瘤对治疗的临床反应非常好,但乳糜胸仍然存在,并且对胸部导管进行了经皮放疗。但是,放疗后八周,乳糜胸仍持续存在,我们的患者同意进行手术干预。通过保留肌肉的胸廓切开术对胸导管进行结扎,导致胸腔积液完全停止。除前两周外,我们的患者在门诊治疗了近六个月。结论在这种由慢性淋巴细胞性白血病引起的乳糜胸的病例中,尽管慢性淋巴细胞性白血病对治疗的临床反应非常好,但是免疫化学疗法与保守治疗相结合甚至连续放疗仍不能停止胸腔积液。使用桥接胸腔穿刺术的门诊治疗可以安全地桥接,直到明确的胸导管结扎术。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号